Stockscreener 앱 받기
7.60
1.68%
-0.13
시간 외 거래:
7.64
0.04
+0.53%
전일 마감가:
$7.73
열려 있는:
$7.7
하루 거래량:
30,967
Relative Volume:
1.67
시가총액:
$68.76M
수익:
$27.64M
순이익/손실:
$-1.04M
주가수익비율:
-66.84
EPS:
-0.1137
순현금흐름:
$1.22M
1주 성능:
+19.12%
1개월 성능:
+19.31%
6개월 성능:
+14.63%
1년 성능:
+41.00%
1일 변동 폭
$7.50
$7.805
1주일 범위
$6.75
$7.82
52주 변동 폭
$4.52
$7.82
Immucell Corp Stock (ICCC) Company Profile
명칭
Immucell Corp
전화
(207) 878-2770
주소
56 EVERGREEN DR, PORTLAND, ME
Compare ICCC vs VRTX, REGN, ARGX, ALNY, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ICCC
Immucell Corp
|
7.60 | 69.93M | 27.64M | -1.04M | 1.22M | -0.1137 |
VRTX
Vertex Pharmaceuticals Inc
|
441.70 | 113.01B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
753.93 | 79.87B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
840.87 | 51.51B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
333.39 | 45.29B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
319.94 | 34.41B | 5.36B | 287.73M | 924.18M | 2.5229 |
Immucell Corp 주식(ICCC)의 최신 뉴스
650K-share equity plan and officer exculpation up for vote — ImmuCell (NASDAQ: ICCC) - Stock Titan
ImmuCell (ICCC) VP Brockmann granted 5,000 incentive stock options - Stock Titan
ImmuCell (ICCC) director receives grant of 10,000 stock options - Stock Titan
ImmuCell (ICCC) director awarded 10,000 stock options at $5.49 strike - Stock Titan
ImmuCell (ICCC) director awarded 10,000 options at $5.49 exercise price - Stock Titan
ImmuCell (ICCC) director Steven Rosgen granted 10,000 stock options at $5.49 - Stock Titan
ImmuCell (ICCC) director receives 10,000 non-qualified stock options at $5.49 - Stock Titan
ImmuCell (ICCC) adds industry veterans to a smaller, more independent board - Stock Titan
ImmuCell appoints two directors, expands to 7-member board - Investing.com
ImmuCell appoints two directors, expands to 7-member board By Investing.com - Investing.com South Africa
Two animal health veterans join ImmuCell as board shrinks to 7 - Stock Titan
ICCC SEC FilingsImmucell 10-K, 10-Q, 8-K Forms - Stock Titan
ImmuCell Corporation Reports 35.7% Increase in Domestic Sales for 2026 – SEC 8-K Filing Highlights - Minichart
ImmuCell reports 28% sales increase in first quarter - Investing.com
ImmuCell Announces a 28.4% Increase in Product Sales in Q1 of 2026, based on Preliminary, Unaudited Sales Results - The Manila Times
ImmuCell (ICCC) Q1 2026 sales jump 28.4% on Tri-Shield strength - Stock Titan
Immucell Corporation Announces Preliminary, Unaudited Sales Results for the Firs Quarter of 2026 - marketscreener.com
Published on: 2026-04-08 23:34:29 - baoquankhu1.vn
IMMUCELL (ICCC) director Kathy V. Turner files initial insider Form 3 - Stock Titan
ICCC PE Ratio & Valuation, Is ICCC Overvalued - Intellectia AI
Volume Report: Will ImmuCell Corporation be affected by tariffs2026 Market Trends & Low Risk Entry Point Guides - baoquankhu1.vn
ImmuCell (NASDAQ: ICCC) boosts 2025 margins, shifts from Re‑Tain to core First Defense calf-health line - Stock Titan
ImmuCell (NASDAQ:ICCC) Stock Crosses Above 200 Day Moving AverageHere's Why - MarketBeat
ImmuCell (NASDAQ:ICCC) Stock Crosses Above 200 Day Moving Average – Here’s Why - Defense World
ICCC Technical Analysis | Trend, Signals & Chart Patterns | IMMUCELL CORP (NASDAQ:ICCC) - chartmill.com
ImmuCell (ICCC) director exercises 25,000 options and ends with 205,700 shares - Stock Titan
ImmuCell (ICCC) CEO granted 109,500 stock options with strict profit hurdle - Stock Titan
ImmuCell Corporation Files Form 8-K with SEC Detailing Corporate Information and Press Release March 2026 - Minichart
ImmuCell appoints Kathy Turner to board of directors - Investing.com
ImmuCell (NASDAQ: ICCC) names Kathy Turner to Board as Rosgen retires - Stock Titan
Former Elanco director joins ImmuCell board in calf-health push - Stock Titan
ImmuCell Corp (ICCC) Q4 2025 Earnings Call Highlights: Navigating Growth Amidst Challenges By GuruFocus - Investing.com Canada
ImmuCell 2025 Net Loss Narrows Y/Y as Sales & Margins Improve - Yahoo Finance
ImmuCell Corporation (NASDAQ:ICCC) Q4 2025 Earnings Call Transcript - Insider Monkey
ImmuCell Q4 Earnings Call Highlights - Yahoo Finance
Earnings call transcript: ImmuCell’s Q4 2025 shows growth despite challenges - Investing.com
ImmuCell Corporation Q4 2025 Earnings Call Summary - Yahoo Finance
ICCC Earnings History & Surprises | EPS & Revenue Results | IMMUCELL CORP (NASDAQ:ICCC) - ChartMill
ImmuCell Corporation Reports Improved Financial Results for 2025 with Increased Net Operating Income and Revenue Growth - Quiver Quantitative
ImmuCell (Nasdaq: ICCC) lifts 2025 EBITDA and narrows annual net loss - Stock Titan
ImmuCell Corporation (NASDAQ:ICCC) Sees Significant Growth in Short Interest - MarketBeat
ImmuCell Corporation to Announce Unaudited Financial Results for Q4 and Year-End 2025 on March 4, 2026 - Quiver Quantitative
ImmuCell (NASDAQ:ICCC) Stock Price Crosses Above 200-Day Moving Average – What’s Next? - Defense World
Does ImmuCell Corporation have a sustainable dividendJuly 2025 WrapUp & Stepwise Entry/Exit Trade Alerts - mfd.ru
Why retail investors pile into ImmuCell Corporation stockJuly 2025 Big Picture & Low Risk Investment Opportunities - mfd.ru
Will ImmuCell Corporation benefit from AI trendsBear Alert & Weekly Momentum Stock Picks - mfd.ru
ImmuCell directors to step down at 2026 annual meeting, board changes expected By Investing.com - Investing.com South Africa
ImmuCell directors to step down at 2026 annual meeting, board changes expected - Investing.com
Two ImmuCell (ICCC) directors to step down after 2026 shareholder meeting - Stock Titan
ImmuCell announces new executive employment agreements and option grants By Investing.com - Investing.com South Africa
ImmuCell announces new executive employment agreements and option grants - Investing.com
Immucell Corp (ICCC) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.69%
0.25%
자본화:
|
볼륨(24시간):